Pierre Fabre and the ICT set up a research chair for law, ethics and health
15 June 2018
The Catholic Institute of Toulouse college (ICT) and Pierre Fabre Group SA have signed a partnership agreement for the creation of a research and training chair focused on the law, ethics and health.
In the presence of:
- Mr. Bertrand Parmentier, CEO, Pierre Fabre SA,
- Mr. Thierry Denjean, Senior Vice-President of Human Resources, Ethics & Sustainable Development
- Fr. Luc-Thomas Somme, OP, Chancellor of the ICT
- General Thierry Cambournac, Chair of the Board of Governors of the ICT
Pierre Fabre Group is committed to incorporating public demand in terms of health care into a seamless health to beauty continuum. With the desire to serve the best interests of all involved, with a particular emphasis on patients and consumers and the greatest respect for the environment, Pierre Fabre is bound by the principles governing ethical conduct within the sector and the need to behave in a socially responsible manner with respect to all its stakeholders and employees, in all the regions in which it is present.
With these essential considerations in mind, Pierre Fabre has for several years already been pursuing an active policy aimed at strengthening ties and cooperation with top academic institutions and colleges, especially in the regions where its company started out. This policy establishes the Group’s role as a true partner of the academic world.
With its resolutely outward-looking approach, the Catholic Institute is fully in touch with the major questions of our time and committed to supporting key players in the social and economic sectors as they fine-tune their ethical stance.
It was therefore only natural that Pierre Fabre and the Catholic Institute of Toulouse should combine their convictions to set up an “Ethics and Health” chair.
Three lines of study have been identified for this Pierre Fabre chair
- Pharmaceutical research: reflection on attempts to influence: analyze the way in which the pharmaceutical industry manages the expectations it generates among the many players it affects (patients, patient families, government officials, etc.) and the various types of pressure it can come under.
- Development assistance for third-world countries: analyze the actions that can be undertaken by businesses, associations and certain national and international public institutions to boost the health sector in the world’s least developed countries.
- The notion of value chains in the health industry: consider the way in which the pharmaceutical industry defines its strategy (choice of research topics, related budgets, etc.) and the constituents of an ethical value chain applied to companies in the health sector.
Under the terms of the chair, lecturers and researchers will undertake to publish various articles written to the highest standards of scientific rigor that define all research work.
In order to enhance the chair’s visibility, some articles will also be published in the specialist press. Publications in the mainstream press will also be encouraged, to ensure that the expertise developed by the chair and its lecturers and researchers is disseminated as widely as possible.
Finally, this research chair will be the backbone of the ICT’s academic courses in the field of Corporate Social Responsibility (CSR) and ethics in the business world.